Results 21 to 30 of about 20,071 (176)

Long-Term Survival due to Chemotherapy including Paclitaxel in a Patient with Metastatic Primary Splenic Angiosarcoma

open access: yesCase Reports in Gastroenterology, 2021
A primary splenic angiosarcoma is a rare type of soft tissue sarcoma and is associated with an extremely poor prognosis. In this study, we describe the case of a patient who was diagnosed with metastatic primary splenic angiosarcoma and survived for ...
Masanori Takehara   +11 more
doaj   +1 more source

A Case of Primary Bilateral Angiosarcoma of the Breast

open access: yes대한영상의학회지, 2016
Angiosarcoma is a malignant tumor of endovascular origin that can occur in any part of the body including the breast; however, angiosarcoma of the breast is quite rare. There are two sub-types of breast angiosarcoma.
Kiwook Lee   +4 more
doaj   +1 more source

Splenic Angiosarcoma Diagnosed on Bone Marrow Biopsy: Case Report and Literature Review

open access: yesRadiology Case Reports, 2019
Primary splenic angiosarcoma carries a poor prognosis and is among the rarest forms of malignancy. An overwhelming majority of patients with splenic angiosarcoma will develop metastases. However, osseous metastatic disease is rare.
Asaph C.J. Levy, MD   +5 more
doaj   +1 more source

Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report

open access: yesSurgical Case Reports, 2020
Background Angiosarcoma of the breast is very rare and can be divided into primary and secondary angiosarcoma. Radiation-induced angiosarcoma (RIAS) is classified as secondary angiosarcoma.
Yoko Suzuki   +15 more
doaj   +1 more source

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature

open access: yesCase Reports in Oncology, 2017
Angiosarcoma of the heart is an uncommon soft tissue sarcoma. A few cases of disseminated intravascular coagulation (DIC) associated with angiosarcoma occurring in various organs, but not the heart, have been reported. Although taxane is commonly used in
Kazunori Honda   +9 more
doaj   +1 more source

Clinical Case: Multifocal Hepatic Angiosarcoma

open access: yes, 2021
Diagnosi differenziale lesioni epatiche con caso clinico di angiosarcoma ...
chiara longo   +3 more
core   +1 more source

Cutaneous angiosarcoma: report of three different and typical cases admitted in a unique dermatology clinic [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: Angiosarcoma is a rare and aggressive tumor with high rates of metastasis and relapse. It shows a particular predilection for the skin and superficial soft tissues.
Aline Neves Freitas Cabral   +5 more
doaj   +1 more source

Primary cardiac tumor: a case report of right atrial angiosarcoma and review of the literature

open access: yesFrontiers in Oncology, 2023
Primary cardiac angiosarcoma is a relatively rare tumor with early metastasis and poor prognosis. Radical resection of the primary tumor remains the primary approach for the optimal survival of patients with early-stage cardiac angiosarcoma without ...
Yujian Guo, Qianzhen Liu, Haibo Wu
doaj   +1 more source

Transarterial chemoembolization for Kasabach-Merritt syndrome caused by hepatic angiosarcoma: A case report

open access: yesRadiology Case Reports, 2021
Hepatic angiosarcoma is a rare disease, and hepatic hemangiosarcoma with Kasabach-Merritt syndrome (KMS) is even rarer. Although there have been several reports about KMS caused by hepatic angiosarcoma, there has been no mention of successful treatment ...
Ziyu Tang, master degree   +5 more
doaj   +1 more source

Primary pure angiosarcoma of the testis: a vanishingly rare malignancy. Case report and literature review

open access: yesBMC Urology, 2020
Background Primary pure angiosarcoma of the testis is an exceptionally rare testicular malignancy, which is poorly understood. We present the fifth and youngest case in the current medical literature.
J. Walravens-Evans   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy